These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 33137356)
1. Effects of Cangfu Daotan Decoction on obese polycystic ovary syndrome and its mechanism. Yi W; Li X; Chen K; Zhu M; Cai X; Pan A Steroids; 2021 Jan; 165():108740. PubMed ID: 33137356 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of cangfu daotan decoction as an adjuvant treatment of Diane-35 for polycystic ovary syndrome: A systematic review and meta-analysis. Feng X; Cheng S; Xu S; Chen X; Zhou X Heliyon; 2024 Sep; 10(17):e36959. PubMed ID: 39281507 [TBL] [Abstract][Full Text] [Related]
3. The ameliorative effect of CangFu Daotan Decoction on polycystic ovary syndrome of rodent model is associated with m6A methylation and Wnt/β-catenin pathway. Zhang Y; Zhou H; Ding C Gynecol Endocrinol; 2023 Dec; 39(1):2181637. PubMed ID: 36822223 [No Abstract] [Full Text] [Related]
4. Analysis on the therapeutic effect of Cangfu Daotan Decoction combined with drospirenone and ethinylestradiol tablets (II) on patients with polycystic ovary syndrome. Fu Y; Xie P; Yang Q; Chen P; Yu J Prostaglandins Other Lipid Mediat; 2024 Feb; 170():106801. PubMed ID: 37984794 [TBL] [Abstract][Full Text] [Related]
6. Protective effect of Yunkang oral liquid via regulating androgen receptor in polycystic ovary syndrome rats. Zheng X; Zhou C; Xu W; Jia J; Li B; Lv G; Chen S Gynecol Endocrinol; 2024 Dec; 40(1):2368845. PubMed ID: 39058911 [No Abstract] [Full Text] [Related]
7. Cangfu Daotan Wan alleviates polycystic ovary syndrome with phlegm-dampness syndrome via disruption of the PKP3/ERCC1/MAPK axis. Li Y; Wu H; Guo Y; Wei C; Guan L; Ju W; Lian F J Ovarian Res; 2023 Jul; 16(1):134. PubMed ID: 37420272 [TBL] [Abstract][Full Text] [Related]
8. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway. Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267 [TBL] [Abstract][Full Text] [Related]
9. Cangfu daotan decoction for polycystic ovary syndrome: A protocol of systematic review and meta-analysis. Park HR; Kim JH; Lee D; Jo HG Medicine (Baltimore); 2019 Sep; 98(39):e17321. PubMed ID: 31574864 [TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone with a high-fat diet treatment at inducing polycystic ovary syndrome in rat model. He Y; Li X; Li Y; Kuai D; Zhang H; Wang Y; Tian W Steroids; 2024 Jun; 206():109424. PubMed ID: 38642598 [TBL] [Abstract][Full Text] [Related]
11. Modified Cangfu Daotan decoction ameliorates polycystic ovary syndrome with insulin resistance Liu S; Zhang Y; Yang F; Gu J; Zhang R; Kuang Y; Mai W; Zheng C; Yu Y; Lu R; Zeng L; Cao H; Long Y Front Endocrinol (Lausanne); 2022; 13():975724. PubMed ID: 36440213 [TBL] [Abstract][Full Text] [Related]
12. Jiawei Buzhong Yiqi Decoction attenuates polycystic ovary syndrome through regulating kisspeptin-GPR54-AKT-SHBG system. Hu R; Geng Y; Huang Y; Liu Z; Li F; Song K; Ma W; Dong H; Zhang M; Lei T; Song Y; Zhang Z Phytomedicine; 2024 Oct; 133():155931. PubMed ID: 39116604 [TBL] [Abstract][Full Text] [Related]
13. Cangfudaotan decoction inhibits mitochondria-dependent apoptosis of granulosa cells in rats with polycystic ovarian syndrome. Jiang XL; Tai H; Xiao XS; Zhang SY; Cui SC; Qi SB; Hu DD; Zhang LN; Kuang JS; Meng XS; Li SM Front Endocrinol (Lausanne); 2022; 13():962154. PubMed ID: 36465612 [TBL] [Abstract][Full Text] [Related]
14. Network pharmacology integrated with experimental validation reveals the regulatory mechanism of action of Hehuan Yin decoction in polycystic ovary syndrome with insulin resistance. Wu YY; Li SY; Zhu HQ; Zhuang ZM; Shao M; Chen FL; Liu CS; Tang QF J Ethnopharmacol; 2022 May; 289():115057. PubMed ID: 35121050 [TBL] [Abstract][Full Text] [Related]
15. [Effect of modified cangfu daotan decoction in improving endometrial receptivity in infertility patients with polycystic ovarian syndrome]. Ding CF; Wang CY; Yang X; Zheng RH; Yan ZZ; Chen WQ Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Nov; 34(11):1297-301. PubMed ID: 25566617 [TBL] [Abstract][Full Text] [Related]
16. Zishen Qingre Lishi Huayu Recipe May Ameliorate the Symptoms of PCOS Model Rats via Alleviating Systemic and Ovarian Inflammation. Li X; Yi Y; Ren Y; Zhang Y; Wang CC; Liu C; Liu S; Zhan X; Yu X; Liang R Am J Reprod Immunol; 2024 Aug; 92(2):e13918. PubMed ID: 39158962 [TBL] [Abstract][Full Text] [Related]
17. Guizhi Fuling Wan reduces autophagy of granulosa cell in rats with polycystic ovary syndrome via restoring the PI3K/AKT/mTOR signaling pathway. Liu M; Zhu H; Zhu Y; Hu X J Ethnopharmacol; 2021 Apr; 270():113821. PubMed ID: 33460753 [TBL] [Abstract][Full Text] [Related]
18. [Effect of Transcutaneuos Acupoint Electrostimulation on Serum Sex Hormone Levels and Expression of Ovarian Steroid Hormone Metabolic Enzymes in Polycystic Ovary Syndrome Rats]. Zhou JY; Zhang XY; Yu ML; Lu SF; Chen X Zhen Ci Yan Jiu; 2016 Feb; 41(1):11-7. PubMed ID: 27141614 [TBL] [Abstract][Full Text] [Related]
19. [Mechanism of Kuntai Capsules in treatment of polycystic ovary syndrome rat models based on AGE-RAGE signal pathway]. Huang JG; Zhang J; Xiang RJ; Wu YY; He TY; Zhao MN; Wang F Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1082-1090. PubMed ID: 38621915 [TBL] [Abstract][Full Text] [Related]
20. [Effects of berberine on LPS /NF-κB and MAPK signaling pathways in PCOS model rats]. Zhao FQ; Zhao Y; Liu JY; Gou YJ; Yang YQ Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Mar; 38(2):181-186. PubMed ID: 36031579 [No Abstract] [Full Text] [Related] [Next] [New Search]